Innovation Growth

Science and Technology Minister Jitendra Singh on Sunday said scientific innovation must not remain confined to laboratories and should translate into impactful, market-ready solutions that empower industries and improve lives. Addressing a meeting of the secretaries of various science departments, Singh cited examples of successful government-supported innovations, encouraging departments to use these stories as models to inspire trust and investment from the private stakeholders. "Scientific innovation must not remain confined to laboratories. It should translate into impactful, market-ready solutions that empower industries and improve lives," he said. Singh said India could establish itself as a global leader in innovation and technology-led solutions by effectively marketing technologies. The minister advocated for frameworks that enable public-private collaboration to fast-track the commercialization of lab-scale breakthroughs. He stressed that such partnerships are essentia

The RBI has taken several measures to prevent and mitigate digital frauds in the financial sector, including the issuance of cybersecurity and cyber fraud prevention guidelines, among others

Red Hat sees India as among the world's high-growing markets, and the country's expanding enterprise base and technical innovation capabilities offer exciting prospects for the IBM-owned company, its CEO Matt Hicks has said. Weighing in on the larger debate of AI and its impact on tech sector jobs and salaries, Hicks told PTI that artificial intelligence, "if done well", will trigger massive value creation and spawn new industries beyond anyone's imagination. Red Hat - the enterprise open-source solutions company that IBM bought in 2019 for about USD 35 billion, marking its biggest acquisition ever - is working with a "great" foundation base in India and is at an exciting point where the company is amplifying capabilities with technology roles. "I think India, at this point, is one of the strongest markets in the world with its fundamentals...When I look at the opportunity in India...one, it is a high-growing market and has enterprise needs, so that is a great fit for us...Also, the

A portable cold chain solution for last-mile vaccine delivery

As a consumer, the government can play a crucial role in unlocking the potential for innovation in Indian companies

The latest centre of Philips in Bengaluru marks a significant landmark in the company's global footprint, alongside, playing a vital role in "revolutionising" healthcare in India and beyond

Union health minister Mansukh Mandaviya on Tuesday asked domestic pharmaceutical industry to focus on the research and development of innovative products to move up the value chain and achieve global leadership. Mandaviya, who also holds the Chemical and Fertilisers portfolio, asked medical technology companies to produce critical equipment in India for the global markets. While formally unveiling the National Policy on Research & Development and Innovation in the Pharma-Med Tech Sector here, Mandaviya said the domestic pharmaceutical companies invest less on research and development when compared to multinational companies. "International MNCs spend 20-25 per cent of their profits in research and innovation while for Indian companies the average is around 10 per cent...Till the time we do not come out with research-led innovative products, we cannot lead the segment globally," he noted. He said the government wants to make the pharma industry self-reliant by 2047. "Today is a ...

The aim of the facility is to create an eco-system that would "focus on promoting access to financial services and products. This will also promote financial inclusion

The upcoming BRICS Summit is scheduled to get open on September 2